Comparison of the opsonic activity of polyclonal and monoclonal antibodies raised against Salmonella minnesota strain R595

References

1. Baumgartner J D. 1985; Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 2:59–63
   [Google Scholar]
2. Braude A I, Ziegler E J, Douglas H, McCutchan J A. 1977; Antibody to cell wall glycolipid of gram-negative bacteria: Induction of immunity to bacteremia and endotoxemia. Journal of Infectious Diseases 136:S167–S173
   [Google Scholar]
3. Clark L A, Easmon C S F. 1986; Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis . Journal of Clinical Pathology 39:856–860
   [Google Scholar]
4. Crowley J P, Zinner S H, Peter G. 1982; Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera. Journal of Laboratory and Clinical Medicine 99:197–205
   [Google Scholar]
5. Dunn D L, Bogard W C, Cerra F B. 1985; Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody. Archives of Surgery 120:50–53
   [Google Scholar]
6. Easmon C S F, Cole P J, Williams A J, Hastings M. 1980; The measurement of opsonic and phagocytic function by luminol-dependent chemiluminescence. Immunology 41:67–74
   [Google Scholar]
7. Galanos C, Luderitz O, Westphal O. 1969; A new method for the extraction of R-lipopolysaccharides. European Journal of Biochemistry 9:245–249
   [Google Scholar]
8. Galanos C, Luderitz O, Westphal O. 1971; Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. European Journal of Biochemistry 24:116–122
   [Google Scholar]
9. Galanos C, Rietschel E T, Luderitz O, Westphal O, Kim Y B, Watson D W. 1972; Biological activities of lipid A complexed with bovine-serum albumin. European Journal of Biochemistry 31:230–233
   [Google Scholar]
10. Galfre G, Milstein C. 1982; Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas. Immunology 45:125–128
    [Google Scholar]
11. Greisman S E, Dubuy J B, Woodward C L. 1978; Experimental gram-negative bacterial sepsis : Re-evaluation of the ability of rough mutant antisera to protect mice. Proceedings of the Society for Experimental Biology and Medicine 158:482–490
    [Google Scholar]
12. Ivanyi J, Davies P. 1980; Monoclonal antibodies against human growth hormone. Molecular immunology 17:287–290
    [Google Scholar]
13. Johns M, Skehill A, McCabe W R. 1983; Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. Journal of Infectious Diseases 147:57–67
    [Google Scholar]
14. Kirkland T N, Ziegler E J. 1984; An immunoprotective monoclonal antibody to lipopolysaccharide. Journal of Immunology 132:2590–2592
    [Google Scholar]
15. Kreger B E, Craven D E, Carting P C, McCabe W R. 1980a; Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. American Journal of Medicine 68:332–343
    [Google Scholar]
16. Kreger B E, Craven D E, McCabe W R. 1980b; Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. American Journal of Medicine 68:344–355
    [Google Scholar]
17. McCabe W R, Burns S C, Craven D E, Johns M. 1977; Cross-reactive antigens: their potential for immunization-induced immunity to gram-negative bacteria. Journal of Infectious Diseases 136:S161–S166
    [Google Scholar]
18. McCutchan J A, Wolf J L, Ziegler E J, Braude A I. 1983; Ineffectiveness of single-dose human antiserum to core glycolipid (Escherichia coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutro-penia. Schweizerische Medizinische Wochenschrift1440–45
    [Google Scholar]
19. Nelles M J, Niswander C A. 1984; Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infection and Immunity 46:677–681
    [Google Scholar]
20. Ng A, Chen C L H, Chang C M, Nowotny A. 1976; Relationship of structure to function in bacterial endotoxins : Serologi-cally cross-reactive components and their effect on protection of mice against some gram-negative infections. Journal of General Microbiology 94:107–116
    [Google Scholar]
21. Pennington J E, Menkes E. 1981; Type-specific vs cross-protective vaccination for gram-negative bacterial pneumonia. Journal of Infectious Diseases 144:599–603
    [Google Scholar]
22. Polin R A, Harris C M. 1985; Monoclonal antibodies against Group B streptococcus. Macario A J L, Macario E C. Monoclonal antibodies against bacteria 1 Academic Press; Orlando, FL:37–58
    [Google Scholar]
23. Rietschel E T, Sidorczyk Z, Zahringer U, Wollenweber H-W, Luderitz O. , 1983; Analysis of the primary structure of lipid A. Anderson L, Unger F M. Bacterial lipopolysaccharides. Structure, synthesis, biological activities American Chemical Society Symposium Series 231, American Chemical Society; Washington, D.C:195–218
    [Google Scholar]
24. Rosenberg M, Gutnick D, Rosenberg E. 1980; Adherence of bacteria to hydrocarbons : A simple method for measuring cell-surface hydrophobicity. FEMS Microbiology Letters 9:29–33
    [Google Scholar]
25. Taylor R L, Conrad H E. 1972; Stoichiometric depolymerization of polyuronides and glucosaminoglycuronans to monosac-charides following reduction of their carbodiimide-acti-vated carboxyl groups. Biochemistry 11:1383–1388
    [Google Scholar]
26. Teng N N H. 1985; Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proceedings of the National Academy of Sciences of the USA 82:1790–1794
    [Google Scholar]
27. Van Dijk W C, Verbrugh H A, Van Erne-Van Der Tol M E, Peters R, Verhoef J. 1981; Escherichia coli antibodies in opsonisation and protection against infection. Journal of Medical Microbiology 14:381–389
    [Google Scholar]
28. Westphal O, Jann K. 1965; Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Whistler R L. Methods in Carbohydrate Chemistry 5 Academic Press; New York:83–91
    [Google Scholar]
29. Wolff S M. 1982; The treatment of gram-negative bacteremia and shock (editorial). New England Journal of Medicine 307:1267–1268
    [Google Scholar]
30. Ziegler E J, Douglas H, Sherman J E, Davis C E, Braude A I. 1973; Treatment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-Gal epimerase-deficient mutant. Journal of Immunology 111:433–438
    [Google Scholar]
31. Ziegler E J, McCutchan J A, Fierer J, Glauser M P, Sadof F J C, Douglas H, Braude A I. 1982; Treatment of gram negative bacteraemia and shock with human antiserum to a mutant Escherichia coli . New England Journal of Medicine 307:1225–1228
    [Google Scholar]
32. Zinner S H, Peter G. 1983; The potential role of cell wall core glycoplipids in the immunoprophylaxis and therapy of gram-negative rod bacteraemia. Easmon C S F, Jeljaszewicz J. Medical Microbiology II Academic Press; London:71–85
    [Google Scholar]